The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Pro-inflammatory Cytokines, Biomarkers, Genetics and the Immune System: A Mechanistic Approach of Depression and Psoriasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, previous studies have reported mixed results as it relates to the relationship between depression and inflammatory biomarkers (9–11).”
From The Impact of Cognitive Behavioral Therapy on Peripheral Interleukin-6 Levels in Depression: A Systematic Review and Meta-Analysis (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3195 · Cited by 1,075
Dalgard, F. J., Gieler, U., Tomas-Aragones, L., Lien, L., Poot, F., Jemec, G. B. E., Misery, L., Szabo, C., Linder, D., Sampogna, F., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.530 · Cited by 968
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Gałecki, P., & Leonard, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-66 · Cited by 629
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Ford, D. E., & Erlinger, T. P. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.1010 · Cited by 544
Zhou, D., Kusnecov, A. W., Shurin, M. R., DePaoli, M., & Rabin, B. S. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243274 · Cited by 494
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Clinical depression and inflammatory risk markers for coronary heart disease
Miller, G. E., Stetler, C. A., Carney, R. M., Freedland, K. E., & Banks, W. A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02863-1 · Cited by 424
Research works printed but not linked: 117
- Brown, 2015, Psychodermatology, Adv Psychosom Med., 34, 123, 10.1159/000369090 · DOI
- Leon, 2013, Psychodermatology: an overview, Semin Cutan Med Surg., 32, 64, 10.12788/j.sder.0002 · DOI
- White, 2015, Depression and HIV Infection are Risk Factors for Incident Heart Failure Among Veterans: Veterans Aging Cohort Study, Circulation., 132, 1630, 10.1161/CIRCULATIONAHA.114.014443 · DOI
- Bisschop, 2004, The longitudinal relation between chronic diseases and depression in older persons in the community: the Longitudinal Aging Study Amsterdam, J Clin Epidemiol., 57, 187, 10.1016/j.jclinepi.2003.01.001 · DOI · Paper page
- Krishnan, 2002, Comorbidity of depression with other medical diseases in the elderly, Biol Psychiatry, 52, 559, 10.1016/S0006-3223(02)01472-5 · DOI · Paper page
- Nicholson, 2006, Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6,362 events among 146,583 participants in 54 observational studies, Eur Heart J., 27, 2763, 10.1093/eurheartj/ehl338 · DOI · Paper page
- Nasir, 2015, Sleep quality and depression in hospitalized congestive heart failure patients, J Pak Med Assoc., 65, 264
- Krishnadas, 2016, Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans, Brain Behav Immun., 51, 29, 10.1016/j.bbi.2015.08.005 · DOI
- Esposito, 2006, An Italian study on psoriasis and depression, Dermatology., 212, 123, 10.1159/000090652 · DOI · Paper page
- Akay, 2002, Assessment of depression in subjects with psoriasis vulgaris and lichen planus, J Eur Acad Dermatol Venereol., 16, 347, 10.1046/j.1468-3083.2002.00467.x · DOI · Paper page
- Gupta, 1989, A psychocutaneous profile of psoriasis patients who are stress reactors. A study of 127 patients, Gen Hosp Psychiatry., 11, 166, 10.1016/0163-8343(89)90036-4 · DOI
- Gupta, 1994, Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria, Psychosom Med., 56, 36, 10.1097/00006842-199401000-00005 · DOI · Paper page
- Fordham, 2015, A pilot study examining mindfulness-based cognitive therapy in psoriasis, Psychol Health Med., 20, 121, 10.1080/13548506.2014.902483 · DOI · Paper page
- Polenghi, 1994, Experience with psoriasis in a psychosomatic dermatology clinic, Acta Derm Venereol Suppl (Stockh)., 186, 65
- Menter, 2010, The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial, J Am Acad Dermatol., 62, 812, 10.1016/j.jaad.2009.07.022 · DOI · Paper page
- Fortune, 2002, A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy, Br J Dermatol., 146, 458, 10.1046/j.1365-2133.2002.04622.x · DOI · Paper page
- Mease, 2010, Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials, Dermatology., 220, 1, 10.1159/000260371 · doi:10.1159/000260371
- Redighieri, 2011, Erythrodermic psoriasis with regression after prophylaxis with isoniazid and antidepressant therapy: case report, An Bras Dermatol., 86, S141, 10.1590/S0365-05962011000700037 · doi:10.1590/s0365-05962011000700037
- Van Voorhees, 2009, Depression and quality of life in psoriasis, Postgrad Med., 121, 154, 10.3810/pgm.2009.07.2040 · DOI
- Palfreeman, 2013, New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast, Drug Des Devel Ther., 7, 201, 10.2147/DDDT.S32713 · DOI
- Cedeno-Laurent, 2011, New insights into HIV-1 primary skin disorders, J Int AIDS Soc., 14, 5, 10.1186/1758-2652-14-5 · DOI · Paper page
- van Beelen, 2007, Interleukin-17 in inflammatory skin disorders, Curr Opin Allergy Clin Immunol., 7, 374, 10.1097/ACI.0b013e3282ef869e · DOI · Paper page
- Zheng, 2007, Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis, Nature., 445, 648, 10.1038/nature05505 · DOI · Paper page
- Lowes, 2008, Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17T cells, J Invest Dermatol., 128, 1207, 10.1038/sj.jid.5701213 · DOI · Paper page
- Ouyang, 2010, Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease, Cytokine Growth Factor Rev., 21, 435, 10.1016/j.cytogfr.2010.10.007 · DOI
- Uyemura, 1993, The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response, J Invest Dermatol., 101, 701, 10.1111/1523-1747.ep12371679 · DOI · Paper page
- Korver, 2006, Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis, Br J Dermatol., 155, 688, 10.1111/j.1365-2133.2006.07403.x · DOI
- Vissers, 2004, The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis, Exp Dermatol., 13, 106, 10.1111/j.0906-6705.2004.00151.x · doi:10.1111/j.0906-6705.2004.00151.x
- Raychaudhuri, 2014, Diagnosis and classification of psoriasis, Autoimmun Rev., 13, 490, 10.1016/j.autrev.2014.01.008 · DOI · Paper page
- Parrish L. Psoriasis: symptoms, treatments and its impact on quality of life. Br J Community Nurs. 2012;17:524,526,528. · doi:10.12968/bjcn.2012.17.11.524
- Nestle, 2009, Psoriasis, N Engl J Med, 361, 496, 10.1056/NEJMra0804595 · DOI · Paper page
- Urpe, 2005, Stress and psychoneuroimmunologic factors in dermatology, Dermatol Clin., 23, 609, 10.1016/j.det.2005.05.017 · DOI
- Halevy, 1993, Beta-adrenergic blocking drugs and psoriasis: the role of an immunologic mechanism, J Am Acad Dermatol., 29, 504, 10.1016/S0190-9622(08)82012-9 · doi:10.1016/s0190-9622(08)82012-9
- Steinkraus, 1993, Beta-adrenergic receptors in psoriasis: evidence for down-regulation in lesional skin, Arch Dermatol Res., 285, 300, 10.1007/BF00371601 · doi:10.1007/bf00371601
- Farber, 1990, The role of cutaneous sensory nerves in the maintenance of psoriasis, Int J Dermatol., 29, 418, 10.1111/j.1365-4362.1990.tb03825.x · doi:10.1111/j.1365-4362.1990.tb03825.x
- Raychaudhuri, 2000, Role of nerve growth factor in RANTES expression by keratinocytes, Acta Derm Venereol., 80, 247, 10.1080/000155500750012108 · doi:10.1080/000155500750012108
- Farber, 1993, Psoriasis: a stress-related disease, Cutis., 51, 322
- Farber, 1986, Stress, symmetry, and psoriasis: possible role of neuropeptides, J Am Acad Dermatol, 14, 305, 10.1016/S0190-9622(86)70034-0 · DOI · Paper page
- Nickoloff, 2000, Is psoriasis a T-cell disease?, Exp Dermatol., 9, 359, 10.1034/j.1600-0625.2000.009005359.x · DOI
- Raychaudhuri, 2000, Nerve growth factor and its receptor system in psoriasis, Br J Dermatol., 143, 198, 10.1046/j.1365-2133.2000.03617.x · doi:10.1046/j.1365-2133.2000.03617.x
- Aloe, 2002, Stress and nerve growth factor: findings in animal models and humans, Pharmacol Biochem Behav., 73, 159, 10.1016/S0091-3057(02)00757-8 · DOI
- Brunoni, 2015, Decreased brainderived neurotrophic factor plasma levels in psoriasis patients, Braz J Med Biol Res., 48, 711, 10.1590/1414-431X20154574 · DOI
- Owczarczyk-Saczonek, 2017, Interleukin-17 as a factor linking the pathogenesis of psoriasis with metabolic disorders, Int J Dermatol., 56, 260, 10.1111/ijd.13420 · DOI
- Campa, 2016, A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies, Expert Opin Investig Drugs., 25, 1337, 10.1080/13543784.2016.1237502 · DOI
- Wasilewska, 2016, Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases, Postepy Dermatol Alergol., 33, 247, 10.5114/ada.2016.61599 · DOI
- Maes, 1995, Evidence for an immune response in major depression: a review and hypothesis, Prog Neuropsychopharmacol Biol Psychiatry., 19, 11, 10.1016/0278-5846(94)00101-M · DOI · Paper page
- Angiolillo, 1995, Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo, J Exp Med., 182, 155, 10.1084/jem.182.1.155 · DOI · Paper page
- Xia, 1996, Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells, Immunopharmacology., 34, 27, 10.1016/0162-3109(96)00111-7 · DOI · Paper page
- Maes, 1999, Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion, Neuropsychopharmacology., 20, 370, 10.1016/S0893-133X(98)00088-8 · DOI · Paper page
- Cattaneo, 2013, Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’, Neuropsychopharmacology., 38, 377, 10.1038/npp.2012.191 · DOI · Paper page
- Miller, 2008, Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression, Biol Psychiatry., 65, 732, 10.1016/j.biopsych.2008.11.029 · DOI · Paper page
- Miller, 2008, Immune system contributions to the pathophysiology of depression, Focus., 6, 36, 10.1176/foc.6.1.foc36 · DOI
- Rosenblat, 2014, Inflamed moods: a review of the interactions between inflammation and mood disorders, Prog Neuropsychopharmacol Biol Psychiatry., 53, 23, 10.1016/j.pnpbp.2014.01.013 · DOI · Paper page
- Motivala, 2005, Inflammatory markers and sleep disturbance in major depression, Psychosom Med., 67, 187, 10.1097/01.psy.0000149259.72488.09 · DOI · Paper page
- Hannestad, 2011, The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis, Neuropsychopharmacology., 36, 2452, 10.1038/npp.2011.132 · DOI · Paper page
- Moon, 2013, Psoriasis and psycho-dermatology, Dermatol Ther (Heidelb), 3, 117, 10.1007/s13555-013-0031-0 · DOI
- Moller, 2012, Social isolation rearing induces immunological, neurochemical, mitochondrial and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine, Brain Behav Immun., 18, 156
- Persoons, 1995, Acute stress affects cytokines and nitric oxide production by alveolar macrophages differently, Am J Respir Crit Care Med., 152, 619, 10.1164/ajrccm.152.2.7633716 · DOI
- Nguyen, 1998, Exposure to acute stress induces brain interleukin-1beta protein in the rat, J Neurosci., 18, 2239, 10.1523/JNEUROSCI.18-06-02239.1998 · DOI · Paper page
- Maier, 1995, Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock, Brain Res., 695, 279, 10.1016/0006-8993(95)00930-O · DOI · Paper page
- Kubera, 1996, Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression, Pol J Pharmacol., 48, 503
- Kubera, 2011, In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression, Prog Neuropsychopharmacol Biol Psychiatry., 35, 744, 10.1016/j.pnpbp.2010.08.026 · DOI · Paper page
- Bouhuys, 2004, Potential psychosocial mechanisms linking depression to immune function in elderly subjects, Psychiatry Res., 127, 237, 10.1016/j.psychres.2004.05.001 · DOI
- Musselman, 2001, Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings, Am J Psychiatry., 158, 1252, 10.1176/appi.ajp.158.8.1252 · DOI · Paper page
- Kahl, 2005, Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder, Am J Psychiatry., 162, 168, 10.1176/appi.ajp.162.1.168 · DOI
- Tiemeier, 2003, Inflammatory proteins and depression in the elderly, Epidemiology., 14, 103, 10.1097/00001648-200301000-00025 · DOI · Paper page
- Schlatter, 2004, Monocytic parameters in patients with dysthymia versus major depression, J Affect Disord., 78, 243, 10.1016/S0165-0327(02)00316-6 · DOI
- Levine, 1999, Cerebrospinal cytokine levels in patients with acute depression, Neuropsychobiology., 40, 171, 10.1159/000026615 · DOI · Paper page
- Rajagopalan, 2001, Abnormal brachial artery flow-mediated vasodilation in young adults with major depression, Am J Cardiol., 88, 196, 10.1016/S0002-9149(01)01623-X · DOI · Paper page
- Sluzewska, 1995, Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine, Ann NY Acad Sci., 762, 474, 10.1111/j.1749-6632.1995.tb32372.x · DOI · Paper page
- Maes, 1997, Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression, Cytokine., 9, 853, 10.1006/cyto.1997.0238 · DOI · Paper page
- Mikova, 2001, Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis, Eur Neuropsychopharmacol., 11, 203, 10.1016/S0924-977X(01)00081-5 · DOI · Paper page
- Sluzewska, 1997, Changes in acute-phase proteins during lithium potentiation of antidepressants in refractory depression, Neuropsychobiology., 35, 123, 10.1159/000119332 · DOI · Paper page
- Tuglu, 2003, Increased serum tumor necrosis factor- α levels and treatment response in major depressive disorder, Psychopharmacology (Berl)., 170, 429, 10.1007/s00213-003-1566-z · DOI · Paper page
- Owen, 2001, Raised levels of plasma interleukin-1beta in major and postviral depression, Acta Psychiatr Scand., 103, 226, 10.1034/j.1600-0447.2001.00162.x · DOI · Paper page
- Thomas, 2005, Increase in interleukin-1β in late-life depression, Am J Psychiatry., 162, 175, 10.1176/appi.ajp.162.1.175 · DOI · Paper page
- Raison, 2006, Cytokines sing the blues: inflammation and the pathogenesis of depression, Trends Immunol., 27, 24, 10.1016/j.it.2005.11.006 · DOI · Paper page
- Bonaccorso, 2002, Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus, J Affect Disord., 72, 237, 10.1016/S0165-0327(02)00264-1 · DOI · Paper page
- Lotrich, 2009, Major depression during interferon-α treatment: vulnerability and prevention, Dial Clin Neurosci., 11, 417, 10.31887/DCNS.2009.11.4/felotrich · DOI
- Beretta, 2008, A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation, Arthritis Res Ther., 10, R103, 10.1186/ar2495 · doi:10.1186/ar2495
- Dunn, 2005, Cytokines as mediators of depression: what can we learn from animal studies?, Neurosci Biobehav Rev, 29, 891, 10.1016/j.neubiorev.2005.03.023 · DOI · Paper page
- Maes, 2011, Prog Neuro-Psychopharmacol Biol Psychiatry., 35, 702, 10.1016/j.pnpbp.2010.12.017 · DOI · Paper page
- Wang, 1998, Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism, Neurochem Int., 33, 143, 10.1016/S0197-0186(98)00016-3 · DOI
- Maes, 2011, Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways, Neuro Endocrinol Lett., 32, 7
- Al’Abadie, 1994, The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions, Br J Dermatol., 130, 199, 10.1111/j.1365-2133.1994.tb02900.x · DOI · Paper page
- Devrimci-Ozguven, 2000, The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients, J Eur Acad Dermatol Venereol., 14, 267, 10.1046/j.1468-3083.2000.00085.x · DOI · Paper page
- Magin, 2008, Experiences of appearance-related teasing and bullying in skin diseases and their psychological sequelae: results of a qualitative study, Scand J Caring Sci., 22, 430, 10.1111/j.1471-6712.2007.00547.x · DOI
- Fava, 1980, Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections, Br J Med Psychol., 53, 277, 10.1111/j.2044-8341.1980.tb02551.x · DOI · Paper page
- Gupta, 1993, Suicidal ideation in psoriasis, Int J Dermatol., 32, 188, 10.1111/j.1365-4362.1993.tb02790.x · DOI · Paper page
- Hardy, 1982, A study of depression and obsessionality in dysmorphophobic and psoriatic patients, Br J Psychiatry., 140, 19, 10.1192/bjp.140.1.19 · DOI
- Dowlati, 2010, A meta-analysis of cytokines in major depression, Biol Psychiatry., 67, 446, 10.1016/j.biopsych.2009.09.033 · DOI · Paper page
- Breuer, 2016, Relationship between chronic stress and CRP levels in women with psoriasis, J Dtsch Dermatol Ges., 14, 528
- Schmid-Ott, 2009, Immunological effects of stress in psoriasis, Br J Dermatol., 160, 782, 10.1111/j.1365-2133.2008.09013.x · DOI
- Brown, 1987, Depressed mood and reality disturbance correlate with decreased nocturnal melatonin in depressed patients, Acta Psychiatr Scand., 76, 272, 10.1111/j.1600-0447.1987.tb02895.x · DOI
- Kartha, 2014, Serum melatonin levels in psoriasis and associated depressive symptoms, Clin Chem Lab Med., 52, 1, 10.1515/cclm-2013-0957 · DOI
- Sandyk, 1990, Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin, Int J Neurosci., 50, 215, 10.3109/00207459008987174 · DOI
- Carrillo-Vico, 2013, Melatonin: buffering the immune system, Int J Mol Sci., 14, 8638, 10.3390/ijms14048638 · DOI · Paper page
- Esposito, 2010, Anti-inflammatory activity of melatonin in central nervous system, Curr Neuropharmacol., 8, 228, 10.2174/157015910792246155 · DOI · Paper page
- Mozzanica, 1988, Plasma melatonin levels in psoriasis, Acta Derm Venereol., 68, 312
- Miles, 1987, Melatonin: perspectives in laboratory medicine and clinical research, Crit Rev Clin Lab Sci., 25, 231, 10.3109/10408368709105884 · DOI
- Ozler, 2010, Comparison of the effect of topical and systemic melatonin administration on delayed wound healing in rats that underwent pinealectomy, Scand J Clin Lab Invest., 70, 447, 10.3109/00365513.2010.506926 · DOI
- Sandyk, 1990, Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin, Int J Neurosci, 50, 215, 10.3109/00207459008987174 · DOI
- Johnson, 1996, PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T-lymphocytes, Photochem Photobiol., 63, 566, 10.1111/j.1751-1097.1996.tb05657.x · DOI
- Laing, 1995, Ultraviolet light and 8-methoxypsoralen inhibit expression of endothelial adhesion molecules, J Rheumatol., 22, 2126
- Sethi, 2004, Role of p38 mitogen-activated protein kinase and caspases in UV-B-induced apoptosis of murine peritoneal macrophages, Photochem Photobiol., 79, 48
- Singh, 2010, 8-Methoxypsoralen plus ultraviolet a therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder, J Immunol., 184, 7257, 10.4049/jimmunol.0903719 · DOI
- Diffey, 1980, Ultraviolet radiation physics and the skin, Phys Med Biol., 25, 405, 10.1088/0031-9155/25/3/001 · DOI
- Kannan, 2013, The role of tumor necrosis factor-α and other cytokines in depression: what dermatologists should know, J Dermatolog Treat., 24, 148, 10.3109/09546634.2011.619159 · DOI
- Golpour, 2012, Depression and anxiety disorders among patients with psoriasis: a hospitalbased case-control study, Dermatol Res Pract., 2012, 381905, 10.1155/2012/381905 · DOI
- Demirhan, 2012, Identification of chromosome abnormalities in screening of a family with manic depression and psoriasis: predisposition to aneuploidy, Asian J Psychiatr., 5, 169, 10.1016/j.ajp.2012.02.005 · DOI
- Tohid, 2016, A Psychodermatological Phenomenon, Skin Pharmacol Physiol., 29, 220, 10.1159/000448122 · DOI
- Pompili, 2016, Suicide risk and psychiatric comorbidity in patients with psoriasis, J Int Med Res., 44, 61, 10.1177/0300060515593253 · DOI
- Sbidian, 2016, Suicide and psoriasis: no longer an association, Br J Dermatol., 175, 456, 10.1111/bjd.14900 · doi:10.1111/bjd.14900
- Gooderham, 2016, A Review of Psoriasis, Therapies, and Suicide, J Cutan Med Surg., 20, 293, 10.1177/1203475416648323 · DOI
- Innamorati, 2016, Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis, Compr Psychiatry., 70, 200, 10.1016/j.comppsych.2016.08.001 · DOI
- Gravani, 2014, Synthetic antimalarial drugs and the triggering of psoriasis — do we need disease-specific guidelines for the management of patients with psoriasis at risk of malaria?, Int J Dermatol., 53, 327, 10.1111/ijd.12231 · DOI
- Fry, 2007, Triggering psoriasis: the role of infections and medications, Clin Dermatol., 25, 606, 10.1016/j.clindermatol.2007.08.015 · DOI · Paper page
Cited by
Ma, H., Xu, J., Li, R., McIntyre, R. S., Teopiz, K. M., Cao, B., & Yang, F. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.844176 · Cited by 22
Metadata
- Authors
- Aleem, D., & Tohid, H.
- Venue
- Revista Colombiana de Psiquiatría
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 47
- Issue
- 3
- Pages
- 177-186
- ISSN
- 0034-7450
- Cited by
- 32
- References
- 20
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pro-inflammatory Cytokines, Biomarkers, Genetics and the Immune System: A Mechanistic Approach of Depression and Psoriasis. https://app.cochat.ai/papers/10.1016/j.rcp.2017.03.002
- The paper
- Aleem, D., & Tohid, H. (2018). Pro-inflammatory Cytokines, Biomarkers, Genetics and the Immune System: A Mechanistic Approach of Depression and Psoriasis. Revista Colombiana de Psiquiatría. https://doi.org/10.1016/j.rcp.2017.03.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.